Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Anosmia × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1 Genitourinary 1

Conditions

Lymphoma 2320 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1846 Lymphoma, Non-Hodgkin 1834 Leukemia, Lymphocytic, Chronic, B-Cell 1569 Lymphoma, Follicular 1459 Lymphoma, Large B-Cell, Diffuse 1416 Leukemia 1068 Hodgkin Disease 1010 Lymphoma, Mantle-Cell 989 Burkitt Lymphoma 790 Leukemia, Myeloid, Acute 776 Lymphoma, B-Cell, Marginal Zone 693 Recurrence 688 Multiple Myeloma 660 Lymphoma, B-Cell 610 Myelodysplastic Syndromes 542 Neoplasms 434 Lymphoma, T-Cell, Cutaneous 430 Waldenstrom Macroglobulinemia 413 Lymphoma, Large-Cell, Immunoblastic 410 Mycosis Fungoides 343 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 328 Lymphoma, Large-Cell, Anaplastic 320 Sezary Syndrome 290 Lymphoma, T-Cell, Peripheral 281 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 270 Hematologic Neoplasms 265 Myeloproliferative Disorders 256 Neoplasms, Plasma Cell 238 Blast Crisis 234

Interventions

Surveys and Questionnaires 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04716153 2026-01-20

RE-NEZ-SENS

University Hospital, Montpellier

Phase NA Terminated

LymphoidPlasma cell

Anosmia, Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡